No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MMSI241220P130000
- 0.00
- 0.000.00%
15min DelayClose Dec 20 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest130.00Strike Price0.00Turnover0.00%IV-32.36%PremiumDec 20, 2024Expiry Date31.78Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma3.07Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Merit Medical Systems Insiders Sold US$556k Of Shares Suggesting Hesitancy
CCORF Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $127
Needham Maintains Merit Medical Systems(MMSI.US) With Buy Rating, Maintains Target Price $109
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX), Vivani Medical (VANI) and Merit Medical Systems (MMSI)
Merit Medical Systems Says Wrapsody Endoprosthesis Receives FDA Premarket Approval
Express News | Merit Medical Systems Inc - to Begin Commercialization of Wrapsody in USA in 2025